NDC 54643-5646-01 - Infuvite Pediatric
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 54643-5646
- Requested NDC
- 54643-5646-01
- Package NDCs from labels
- 54643-5646-1, 54643-5646-0, 54643-5646-01
- Manufacturer
- Sandoz Inc
- Effective date
- 2024-11-20
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| multiple vitamins injection - Sandoz Inc | Sandoz Inc | 2024-11-20 | HUMAN PRESCRIPTION DRUG LABEL |
| PEDIATRIC INFUVITE MULTIPLE VITAMINS FOR INFUSION - Sandoz Inc | Sandoz Inc | 2016-03-28 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 54643-5646-1 | Infuvite Pediatric | 1 in 1 CARTON | KIT | 1 | 17 | |
| 54643-5648-1 | Infuvite Pediatric | 4 mL in 1 VIAL | INJECTION, SOLUTION | 20 mL | 0.2 mg in 4mL | 17 |
| 54643-5651-1 | Infuvite Pediatric | 1 mL in 1 VIAL | INJECTION, SOLUTION | 5 mL | 140 ug in 1mL | 17 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 54643-5646 | INFUVITE PEDIATRIC (MULTIPLE VITAMINS INJECTION) KIT [SANDOZ INC] | 17 | Current NDC, Legacy NDC, 3 package rows | 20241206_6d06546e-8b0a-4490-82d9-397bd902a044.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 54643-5646-1 | ML - Milliliter | 54643-5646 | 0d38a887-095e-449f-bb59-323aa721de23 | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| XYCOS PINK COLLAGEN TONER | ADENOSINE, NIACINAMIDE | NOKSIBCHO cosmetic Co., Ltd. | a22d5d31-4c3f-651c-e053-2a95a90ae541 | 2020-03-31 | Warnings | 25X51I8RD4 |
| THE SKIN HOUSE ROSE HEAVEN | ADENOSINE, NIACINAMIDE | NOKSIBCHO cosmetic Co., Ltd. | a21c097c-82ac-3a21-e053-2995a90a63eb | 2020-03-30 | Warnings | 25X51I8RD4 |
| THE SKIN HOUSE Rose HeavenCream | ADENOSINE, NIACINAMIDE | NOKSIBCHO cosmetic Co., Ltd. | a21ba34c-2d2d-8033-e053-2995a90a1d74 | 2020-03-30 | Warnings | 25X51I8RD4 |
| THE SKIN HOUSE ROSE HEAVEN SERUM | ADENOSINE, NIACINAMIDE | NOKSIBCHO cosmetic Co., Ltd. | a21c72f8-00ff-0971-e053-2995a90a2f97 | 2020-03-30 | Warnings | 25X51I8RD4 |
| THE SKIN HOUSE Vital BrightCream | NIACINAMIDE | NOKSIBCHO cosmetic Co., Ltd. | a21cbf42-482c-2d95-e053-2a95a90a1a48 | 2020-03-30 | Warnings | 25X51I8RD4 |
| THE SKIN HOUSE Vital Bright Emulsion | NIACINAMIDE | NOKSIBCHO cosmetic Co., Ltd. | a21d0eba-a96c-72e8-e053-2995a90addfb | 2020-03-30 | Warnings | 25X51I8RD4 |
| THE SKIN HOUSE Vital Bright EyeCream | NIACINAMIDE | NOKSIBCHO cosmetic Co., Ltd. | a21d3c87-0a7f-2e15-e053-2a95a90aee69 | 2020-03-30 | Warnings | 25X51I8RD4 |
| THE SKIN HOUSE Vital BrightSerum | NIACINAMIDE | NOKSIBCHO cosmetic Co., Ltd. | a21d8184-258f-679e-e053-2995a90ad7c4 | 2020-03-30 | Warnings | 25X51I8RD4 |
| THE SKIN HOUSE Vital Bright Toner | NIACINAMIDE | NOKSIBCHO cosmetic Co., Ltd. | a21daae8-98d6-203a-e053-2a95a90aafe5 | 2020-03-30 | Warnings | 25X51I8RD4 |
| Sterile Water | WATER | Baxter Healthcare Company | 8bcf5572-49e1-4302-9522-56f57904cb4a | 2019-12-29 | Warnings, Adverse reactions | 059QF0KO0R |
| Renacidin | CITRIC ACID, GLUCONOLACTONE AND MAGNESIUM CARBONATE | United-Guardian, Inc. | 13a9bbba-db21-4cba-991c-5d8afaf2ed74 | 2019-12-17 | Warnings, Adverse reactions | XF417D3PSL |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | e41adb4e-06fb-4141-ba55-50b043f3c9da | 2019-11-19 | XF417D3PSL | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 14445dfd-6041-40cd-a043-3f4da6bcb9c1 | 2019-11-18 | XF417D3PSL | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 2557199a-5f60-49d8-b093-1e0700211243 | 2019-11-18 | XF417D3PSL | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 794f724c-87f0-49c1-9b26-c9e491978313 | 2019-11-18 | XF417D3PSL | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 5c7d3287-883a-459b-9214-074a583c8a59 | 2019-11-18 | XF417D3PSL | |
| CPDA-1 | ANTICOAGULANT CITRATE PHOSPHATE DEXTROSE ADENINE | Fenwal, Inc. | 448a1dc5-7a98-4b2f-82af-4b92de05cfc3 | 2019-11-18 | XF417D3PSL | |
| PHYTONADIONE PHYTONADIONE | PHYTONADIONE | Dr.Reddy's Laboratories Inc | 02445c07-7b4b-cd70-54e8-ebefc814f547 | 2019-05-30 | Boxed warning, Warnings, Adverse reactions | A034SE7857 |
| FOLIC ACID | FOLIC ACID | Leading Pharma, LLC | 1ba8c407-9613-4319-ac40-0a429cb0f3f4 | 2019-02-19 | Warnings, Adverse reactions | 935E97BOY8 |
| Folic Acid | FOLIC ACID | Aphena Pharma Solutions - Tennessee, LLC | d6c7ac9b-f44a-4f10-9d1d-efbebd37c313 | 2019-02-12 | Warnings, Adverse reactions | 935E97BOY8 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.